Bank of New York Mellon Corp - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$532,975
-50.2%
74,856
-28.7%
0.00%
Q2 2023$1,070,072
+226.0%
105,012
+190.2%
0.00%
Q1 2023$328,198
+33.8%
36,185
+5.8%
0.00%
Q4 2022$245,257
+10.0%
34,2060.0%0.00%
Q3 2022$223,000
+35.2%
34,2060.0%0.00%
Q2 2022$165,000
-15.8%
34,206
-1.1%
0.00%
Q1 2022$196,000
+13.3%
34,603
-0.1%
0.00%
Q4 2021$173,000
-24.8%
34,6430.0%0.00%
Q3 2021$230,000
+9.0%
34,6430.0%0.00%
Q2 2021$211,000
-31.9%
34,643
-25.8%
0.00%
Q1 2021$310,000
+24.5%
46,677
-0.8%
0.00%
Q4 2020$249,000
+132.7%
47,077
+226.1%
0.00%
Q3 2020$107,000
+0.9%
14,4380.0%0.00%
Q2 2020$106,000
+76.7%
14,438
-28.1%
0.00%
Q1 2019$60,000
-21.1%
20,068
-0.5%
0.00%
Q4 2018$76,000
-36.1%
20,168
-0.2%
0.00%
Q3 2018$119,000
+40.0%
20,208
+35.0%
0.00%
Q2 2018$85,000
-52.8%
14,966
+3.0%
0.00%
Q1 2018$180,000
-56.5%
14,525
-57.6%
0.00%
Q4 2017$414,00034,2690.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RA Capital Management 3,247,005$10,358,0000.56%
Orbimed Advisors 3,409,865$10,877,0000.17%
Eversept Partners, LP 174,297$556,0070.16%
Alambic Investment Management, L.P. 59,847$191,0000.12%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,500$196,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 36,921$118,0000.00%
Paloma Partners Management Co 30,000$96,0000.00%
Tower Research Capital LLC (TRC) 3,211$10,0000.00%
SG Americas Securities, LLC 12,877$41,0000.00%
MEEDER ASSET MANAGEMENT INC 967$3,0000.00%
View complete list of SCPHARMACEUTICALS INC shareholders